{
  "id": 798,
  "text": "When in these situations an adequate type of radical hysterectomy has been performed (Figure 3), observation is an alternative option, especially in teams experienced in this approach.After primary radical surgery, adjuvant chemoradiotherapy is indicated in the following groups of patients (see Principles of radiotherapy): metastatic involvement of PLNs, including the presence of macrometastases pN1 or micrometastases pN1(mi) in either SN or any other PLNs detected by intraoperative or final pathologic assessment $\\Rightarrow$ chemoradiotherapy positive surgical margins (vagina/parametria) $\\Rightarrow$ chemoradiotherapy, brachytherapy boost may be considered parametrial involvement $\\Rightarrow$ chemoradiotherapy # 10.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: When in these situations an adequate type of radical hysterectomy has been performed (Figure 3), observation is an alternative option, especially in teams experienced in this approach.After primary radical surgery, adjuvant chemoradiotherapy is indicated in the following groups of patients (see Principles of radiotherapy): metastatic involvement of PLNs, including the presence of macrometastases p\n\n<question>: ",
  "ChatGPT_response_0": "根据文中提到的情况和原则，对于存在盆腔淋巴结转移的患者，在手术后的治疗方案应该根据具体情况来确定。如果已经进行了足够的根治性子宫切除手术并且在术中或最终病理评估中检测到盆腔淋巴结的转移，那么通常建议接受辅助化疗放疗。这种治疗方案通常适用于转移性盆腔淋巴结受累的患者，包括在术中或最终病理评估中检测到的SN或其他任何淋巴结存在巨细胞转移或微转移的情况。此外，如果手术切缘呈阳性（如阴道或盆壁组织），也会考虑进行化疗放疗。对于这些患者，化疗放疗是一种常规的治疗选择。当然，在确定最佳治疗方案时，应该根据患者的具体情况和实际情况进行综合评估和决策。希望这些信息能帮助您更了解接下来的治疗方案。如果对治疗方案有任何疑问或需要进一步解释，请咨询您的医疗专家。",
  "query": "在手术后，对于存在盆腔淋巴结转移的患者，基于文中提到的情况和原则，您认为接下来的治疗方案应该是什么？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在手术后，对于存在盆腔淋巴结转移的患者，基于文中提到的情况和原则，您认为接下来的治疗方案应该是什么？\n\n<reference text>: When in these situations an adequate type of radical hysterectomy has been performed (Figure 3), observation is an alternative option, especially in teams experienced in this approach.After primary radical surgery, adjuvant chemoradiotherapy is indicated in the following groups of patients (see Principles of radiotherapy): metastatic involvement of PLNs, including the presence of macrometastases pN1 or micrometastases pN1(mi) in either SN or any other PLNs detected by intraoperative or final pathologic assessment $\\Rightarrow$ chemoradiotherapy positive surgical margins (vagina/parametria) $\\R\n\n<reply>: ",
  "response": "根据文中提到的情况和原则，对于存在盆腔淋巴结转移的患者，在手术后的治疗方案应该根据具体情况来确定。如果已经进行了足够的根治性子宫切除手术并且在术中或最终病理评估中检测到盆腔淋巴结的转移，那么通常建议接受辅助化疗放疗。这种治疗方案通常适用于转移性盆腔淋巴结受累的患者，包括在术中或最终病理评估中检测到的SN或其他任何淋巴结存在巨细胞转移或微转移的情况。此外，如果手术切缘呈阳性（如阴道或盆壁组织），也会考虑进行化疗放疗。对于这些患者，化疗放疗是一种常规的治疗选择。当然，在确定最佳治疗方案时，应该根据患者的具体情况和实际情况进行综合评估和决策。希望这些信息能帮助您更了解接下来的治疗方案。如果对治疗方案有任何疑问或需要进一步解释，请咨询您的医疗专家。"
}